OBJECTIVE: The aim of this study was to evaluate the extent to which mild disruptions in ovarian function, indexed by changes in menstrual cycle length, may relate to cardiometabolic and psychological health in premenopausal women. METHODS: Among 804 healthy, regularly cycling women (aged 25-45 y; mean [SD] age, 35.5 [5.5] y), patterns of any change (shortening, lengthening, or increased variability) versus no change in menstrual cycle length were examined in relation to a composite of cardiometabolic risk and individual risk factors (high-density lipoprotein, triglycerides, waist circumference, glucose, and hypertensive status), as well as in relation to depression indicators (Center for Epidemiological Studies Depression Scale score ≥16 [yes/no], lifetime depression diagnosis [yes/no], and lifetime antidepressant medication use [yes/no]). Models were also explored to test whether changes in menstrual cycle length mediated relations between depression history and cardiometabolic risk. RESULTS: In covariate-adjusted models compared with no change, any change in menstrual cycle length was associated with higher cardiometabolic risk composite scores and lower high-density lipoprotein (P < 0.05). In addition, compared with no change, any change in menstrual cycle length was associated with a Center for Epidemiological Studies Depression Scale score of 16 or higher, having received a depression diagnosis, and having used antidepressant medications (P < 0.05). In exploratory analyses, any change in menstrual cycle length partially mediated the relation between depression history and cardiometabolic risk (b = 0.152, P = 0.040), which attenuated (b = 0.129, P = 0.083) when any change in menstrual cycle length was covaried. CONCLUSIONS: Findings suggest that disruptions in ovarian function, marked by subtle changes in menstrual cycle length, may relate to aspects of cardiometabolic and psychological health among healthy, premenopausal women.
OBJECTIVE: The aim of this study was to evaluate the extent to which mild disruptions in ovarian function, indexed by changes in menstrual cycle length, may relate to cardiometabolic and psychological health in premenopausal women. METHODS: Among 804 healthy, regularly cycling women (aged 25-45 y; mean [SD] age, 35.5 [5.5] y), patterns of any change (shortening, lengthening, or increased variability) versus no change in menstrual cycle length were examined in relation to a composite of cardiometabolic risk and individual risk factors (high-density lipoprotein, triglycerides, waist circumference, glucose, and hypertensive status), as well as in relation to depression indicators (Center for Epidemiological Studies Depression Scale score ≥16 [yes/no], lifetime depression diagnosis [yes/no], and lifetime antidepressant medication use [yes/no]). Models were also explored to test whether changes in menstrual cycle length mediated relations between depression history and cardiometabolic risk. RESULTS: In covariate-adjusted models compared with no change, any change in menstrual cycle length was associated with higher cardiometabolic risk composite scores and lower high-density lipoprotein (P < 0.05). In addition, compared with no change, any change in menstrual cycle length was associated with a Center for Epidemiological Studies Depression Scale score of 16 or higher, having received a depression diagnosis, and having used antidepressant medications (P < 0.05). In exploratory analyses, any change in menstrual cycle length partially mediated the relation between depression history and cardiometabolic risk (b = 0.152, P = 0.040), which attenuated (b = 0.129, P = 0.083) when any change in menstrual cycle length was covaried. CONCLUSIONS: Findings suggest that disruptions in ovarian function, marked by subtle changes in menstrual cycle length, may relate to aspects of cardiometabolic and psychological health among healthy, premenopausal women.
Authors: Andrew S Rowland; Donna Day Baird; Stuart Long; Ganesa Wegienka; Siobán D Harlow; Michael Alavanja; Dale P Sandler Journal: Epidemiology Date: 2002-11 Impact factor: 4.822
Authors: W J Gorgels; Y v d Graaf; M A Blankenstein; H J Collette; D W Erkelens; J D Banga Journal: J Clin Epidemiol Date: 1997-03 Impact factor: 6.437
Authors: A Aromaa; R Raitasalo; A Reunanen; O Impivaara; M Heliövaara; P Knekt; V Lehtinen; M Joukamaa; J Maatela Journal: Acta Psychiatr Scand Suppl Date: 1994
Authors: A La Marca; G Sighinolfi; D Radi; C Argento; E Baraldi; A Carducci Artenisio; G Stabile; A Volpe Journal: Hum Reprod Update Date: 2009-09-30 Impact factor: 15.610
Authors: Ankita Prasad; Enrique F Schisterman; Karen C Schliep; Katherine A Ahrens; Lindsey A Sjaarda; Neil J Perkins; Rebecca Matyas; Jean Wactawski-Wende; Sunni L Mumford Journal: Ann Epidemiol Date: 2014-12 Impact factor: 3.797
Authors: Theresa M Hardy; Mauricio Garnier-Villarreal; Donna O McCarthy; Richard A Anderson; Rebecca M Reynolds Journal: West J Nurs Res Date: 2018-08-09 Impact factor: 1.967
Authors: Ene-Choo Tan; Tze-Ern Chua; Theresa M Y Lee; Hui-San Tan; Joe L Y Ting; Helen Y Chen Journal: BMC Pregnancy Childbirth Date: 2015-10-30 Impact factor: 3.007
Authors: Yael I Nillni; Amelia K Wesselink; Elizabeth E Hatch; Ellen M Mikkelsen; Jaimie L Gradus; Kenneth J Rothman; Lauren A Wise Journal: Clin Epidemiol Date: 2018-08-28 Impact factor: 4.790